Related Experiment Video
Updated: Mar 31, 2026
06:35
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
7.9K
Fcγ receptors: genetic variation, function, and disease
Chantal E Hargreaves1,2, Matthew J J Rose-Zerilli1, Lee R Machado3,4
1Cancer Genomics Group, Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Immunological Reviews
|October 27, 2015
Summary
Fc gamma receptors (FcγRs) are crucial for immunity and preventing autoimmunity. Their genetic variations, including copy number and SNPs, impact disease susceptibility and immunotherapy effectiveness.
Area of Science:
- Immunology
- Genetics
- Evolutionary Biology
Background:
- Fc gamma receptors (FcγRs) are critical immune regulators balancing host defense and self-tolerance.
- Dysregulation of FcγR signaling contributes to autoimmunity, cancer, and infection susceptibility.
- Optimal FcγR function is vital for resolving infections and successful monoclonal antibody immunotherapy.
Purpose of the Study:
- To review the evolutionary history of the FcγR gene family in mammals.
- To explore the significance of genetic variations, such as copy number and single nucleotide polymorphisms (SNPs), within the FcγR region.
- To discuss current methodologies and challenges in studying FcγR genetic diversity.
Main Methods:
- Comparative genomics to trace FcγR gene family evolution across mammalian species.
- Analysis of existing literature on FcγR copy number variation and functionally relevant SNPs.
- Review of current genetic and immunological techniques for FcγR research.
Main Results:
- The FcγR gene family exhibits complex evolutionary patterns driven by ancestral duplication events.
- Copy number variations and specific SNPs in FcγRs are associated with altered immune responses.
- Genetic diversity within the FcγR locus influences susceptibility to diseases and therapeutic outcomes.
Conclusions:
- Understanding FcγR evolution and genetic variation is key to comprehending immune system balance.
- FcγR genetic polymorphisms represent important determinants of individual disease risk and treatment response.
- Further research into FcγR genetics is needed to overcome current limitations and improve therapeutic strategies.
More Related Videos
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
112
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
112
01:29Pharmacogenomics: Identification of New Drug Targets
84
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
84
01:27Principles of Pharmacogenetics: Types of Genetic Variants
97
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
97
01:30Transducer Mechanism: G Protein–Coupled Receptors
8.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
8.1K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
68
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
68
01:15G Protein-coupled Receptors
19.6K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
19.6K